Results 221 to 230 of about 416,238 (308)

Electronic health record market consolidation and implications for cybersecurity. [PDF]

Health Aff Sch
Holmgren AJ, Apathy NC, Kanter GP.
europepmc   +1 more source

From cramming to binge‐watching: Integrating documentary‐based assessment into a pharmacology and toxicology curriculum—a qualitative study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims In the context of pharmacology and toxicology education, there is a growing shift toward programmatic assessment models that prioritize longitudinal learning, reflection and development of higher‐order cognitive skills. As part of this transition, we are exploring alternative and more meaningful forms of assessment. This qualitative study
Narin Akrawi, Heleen van der Sijs, Floor van Rosse   +2 more
wiley   +1 more source

Price convergence in grain markets with seasonal differences. [PDF]

PLoS One
Olabisi M, Liu J, Ajibade T, Maredia MK.
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Prevalence, antimicrobial resistance, and extended-spectrum β-lactamase gene profiles of <i>Escherichia coli</i> isolated from poultry eggshells in Can Tho City, Vietnam. [PDF]

Vet World
Lien NT, Huyen TTS, Anh QNT, Dat TM, Duy NK, Phu NT, Khuong TTT.   +6 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Relational embeddedness, organizational learning ambidexterity, and competitive advantage in digital healthcare. [PDF]

Sci Rep
Bai L, Liu X, Leng X, Yao Y, Yang Y, Li D, Zhao Y, Yin H.   +7 more
europepmc   +1 more source

Culture vs. commerce: a dual regulatory approach to television sports rights [PDF]

, 2013
Evens, Tom, Paul, Smith, Petros, Iosifidis   +2 more
core   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source